These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35700523)

  • 1. Do Prostaglandin Analogue Lash Lengtheners Cause Eyelid Fat and Volume Loss?
    Jamison A; Okafor L; Ullrich K; Schiedler V; Malhotra R
    Aesthet Surg J; 2022 Oct; 42(11):1241-1249. PubMed ID: 35700523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin-Associated Periorbitopathy in Children and Young Adults with Glaucoma.
    Kim JS; Blizzard S; Woodward JA; Leyngold IM; Liss J; Freedman SF
    Ophthalmol Glaucoma; 2020; 3(4):288-294. PubMed ID: 33008561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eyelid and eyelash changes due to prostaglandin analog therapy in unilateral treatment cases.
    Yoshino T; Fukuchi T; Togano T; Seki M; Ikegaki H; Abe H
    Jpn J Ophthalmol; 2013 Mar; 57(2):172-8. PubMed ID: 23208023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periorbital changes associated with prostaglandin analogs in Korean patients.
    Kim HW; Choi YJ; Lee KW; Lee MJ
    BMC Ophthalmol; 2017 Jul; 17(1):126. PubMed ID: 28716077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost.
    Kucukevcilioglu M; Bayer A; Uysal Y; Altinsoy HI
    Clin Exp Ophthalmol; 2014 Mar; 42(2):126-31. PubMed ID: 23844550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unilateral Prostaglandin-Associated Periorbitopathy: A Syndrome Involving Upper Eyelid Retraction Distinguishable From the Aging Sunken Eyelid.
    Rabinowitz MP; Katz LJ; Moster MR; Myers JS; Pro MJ; Spaeth GL; Sharma P; Stefanyszyn MA
    Ophthalmic Plast Reconstr Surg; 2015; 31(5):373-8. PubMed ID: 25393907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting the Safety of Prostaglandin Analog Eyelash Growth Products.
    Steinsapir KD; Steinsapir SMG
    Dermatol Surg; 2021 May; 47(5):658-665. PubMed ID: 33625141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse periocular reactions to five types of prostaglandin analogs.
    Inoue K; Shiokawa M; Higa R; Sugahara M; Soga T; Wakakura M; Tomita G
    Eye (Lond); 2012 Nov; 26(11):1465-72. PubMed ID: 23037910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretarsal skin height changes in children receiving topical prostaglandin analogue therapy for primary congenital glaucoma.
    Al-Zobidi M; Khandekar R; Cruz A; Craven RE; Souru C; Malik R; Edward DP
    J AAPOS; 2018 Aug; 22(4):290-293.e1. PubMed ID: 29792934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary on: Do Prostaglandin Analogue Lash Lengtheners Cause Eyelid Fat and Volume Loss?
    Wojno T
    Aesthet Surg J; 2022 Oct; 42(11):1250-1251. PubMed ID: 35695263
    [No Abstract]   [Full Text] [Related]  

  • 11. Eyelash enhancement properties of topical dechloro ethylcloprostenolamide.
    Choy I; Lin S
    J Cosmet Laser Ther; 2008 Jun; 10(2):110-3. PubMed ID: 18569264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of Prostaglandin-Associated Periorbitopathy after Discontinuing Treatment.
    Abalo-Lojo JM; Ferreiro PV; Asorey MK; Colmenero AE; Gonzalez F
    Turk J Ophthalmol; 2023 Feb; 53(1):8-12. PubMed ID: 36847619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Staging of Prostaglandin-Associated Periorbitopathy Syndrome in Glaucoma: A Review from Asia.
    Liu C; Wong T; Leung D; Park HL; Aung T; Aihara M; Makornwattana M; Fang SK; Park KH; Leung C
    Semin Ophthalmol; 2024 Aug; 39(6):424-428. PubMed ID: 38842062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.
    Lin L; Zhao YJ; Chew PT; Sng CC; Wong HT; Yip LW; Wu TS; Bautista D; Teng M; Khoo AL; Lim BP
    Ann Pharmacother; 2014 Dec; 48(12):1585-93. PubMed ID: 25184309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eyelash growth induced by topical prostaglandin analogues, bimatoprost, tafluprost, travoprost, and latanoprost in rabbits.
    Giannico AT; Lima L; Russ HH; Montiani-Ferreira F
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):817-20. PubMed ID: 23981234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bimatoprost-induced chemical blepharoplasty.
    Sarnoff DS; Gotkin RH
    J Drugs Dermatol; 2015 May; 14(5):472-7. PubMed ID: 25942665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eyelash growth from application of bimatoprost in gel suspension to the base of the eyelashes.
    Wester ST; Lee WW; Shi W
    Ophthalmology; 2010 May; 117(5):1024-31. PubMed ID: 20163864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periorbital fat atrophy - an unfamiliar side effect of prostaglandin analogues.
    Jayaprakasam A; Ghazi-Nouri S
    Orbit; 2010 Dec; 29(6):357-9. PubMed ID: 21158579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension.
    Katsanos A; Riva I; Bozkurt B; Holló G; Quaranta L; Oddone F; Irkec M; Dutton GN; Konstas AG
    Expert Opin Drug Saf; 2022 Apr; 21(4):525-539. PubMed ID: 34666576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-sectional survey of the association between bilateral topical prostaglandin analogue use and ocular adnexal features.
    Shah M; Lee G; Lefebvre DR; Kronberg B; Loomis S; Brauner SC; Turalba A; Rhee DJ; Freitag SK; Pasquale LR
    PLoS One; 2013; 8(5):e61638. PubMed ID: 23650502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.